GLO Pharma, Inc. — Form D/A
GLO Pharma, Inc. of Carlsbad, CA, a company, filed a Form D amendment with the SEC on 2022-06-13. The offering totals $33.0M, of which $33.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-06-13
- Form: D/A
- Accession: 0001567619-22-012740
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $33.0M
- Amount sold: $33.0M
- Investors: 116
- Date of first sale: 2021-08-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-413342
Issuer
- Name: GLO Pharma, Inc.
- CIK: 0001832546
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 2810 Caribou Court #130, Carlsbad, CA, 92010
- Phone: (833) 456-7546
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Carol Shen | Director | Carlsbad, CA |
| Scott Glenn | Executive Officer | San Diego, CA |
| Todd Jackson | Director | Philadelphia, PA |
| Lauren Otsuki | Director | San Diego, CA |
| Lauren Otsuki | Executive Officer | San Diego, CA |
| Brent Saunders | Director | Carlsbad, CA |
| Scott Glenn | Director | San Diego, CA |
| Dayna Quanbeck | Director | Carlsbad, CA |
| Nicole Quinn | Director | Los Angeles, CA |
| Marla Beck | Director | Carlsbad, CA |
| Maureen Case | Director | Carlsbad, CA |
| Fabian Seelbach | Director | Carlsbad, CA |
| Douglas Wall | Director | Poway, CA |
| Vimla Black-Gupta | Director | Carlsbad, CA |
| Vimla Black-Gupta | Executive Officer | Carlsbad, CA |
| Jana Messersmith | Director | Encinitas, CA |
Other filings by this issuer (6)
More